Interferon-gamma ameliorates experimental autoimmune encephalomyelitis by inducing homeostatic adaptation of microglia

• Verfasst von: Tichauer, Juan [VerfasserIn]
• Verfasst von: Arellano, Gabriel [VerfasserIn]
• Verfasst von: Acuña, Eric [VerfasserIn]
• Verfasst von: González, Luis F. [VerfasserIn]
• Verfasst von: Kannaiyan, Nirmal R. [VerfasserIn]
• Verfasst von: Murgas, Paola [VerfasserIn]
• Verfasst von: Panadero-Medianero, Concepción [VerfasserIn]
• Verfasst von: Ibañez-Vega, Jorge [VerfasserIn]
• Verfasst von: Burgos, Paula I. [VerfasserIn]
• Verfasst von: Loda, Eileah [VerfasserIn]
• Verfasst von: Miller, Stephen D. [VerfasserIn]
• Verfasst von: Rossner, Moritz J. [VerfasserIn]
• Verfasst von: Gebicke-Härter, Peter J. [VerfasserIn]
• Verfasst von: Naves, Rodrigo [VerfasserIn]
• Titel: Interferon-gamma ameliorates experimental autoimmune encephalomyelitis by inducing homeostatic adaptation of microglia
• Verf.angabe: Juan E. Tichauer, Gabriel Arellano, Eric Acuña, Luis F. González, Nirmal R. Kannaiyan, Paola Murgas, Concepción Panadero-Medianero, Jorge Ibañez-Vega, Paula I. Burgos, Eileah Loda, Stephen D. Miller, Moritz J. Rossner, Peter J. Gebicke-Haerter and Rodrigo Naves
• Jahr: 2023
• Umfang: 22 S.
• Illustrationen: Illustrationen
• Fussnoten: Veröffentlicht: 02. Juni 2023 ; Gesehen am 14.08.2023
• Titel Quelle: Enthalten in: Frontiers in immunology
• Ort Quelle: Lausanne : Frontiers Media, 2010
• Jahr Quelle: 2023
• Band/Heft Quelle: 14(2023), Artikel-ID 1191838, Seite 1-22
• ISSN Quelle: 1664-3224
• DOI: doi:10.3389/fimmu.2023.1191838
• Datenträger: Online-Ressource
• Sprache: eng
• K10plus-PPN: 1856095487

Abstract

Compelling evidence has shown that interferon (IFN)-γ has dual effects in multiple sclerosis and in its animal model of experimental autoimmune encephalomyelitis (EAE), with results supporting both a pathogenic and beneficial function. However, the mechanisms whereby IFN-γ may promote neuroprotection in EAE and its effects on central nervous system (CNS)-resident cells have remained an enigma for more than 30 years. In this study, the impact of IFN-γ at the peak of EAE, its effects on CNS infiltrating myeloid cells (MC) and microglia (MG), and the underlying cellular and molecular mechanisms were investigated. IFN-γ administration resulted in disease amelioration and attenuation of neuroinflammation associated with significantly lower frequencies of CNS CD11b+ myeloid cells and less infiltration of inflammatory cells and demyelination. A significant reduction in activated MG and enhanced resting MG was determined by flow cytometry and immunohistrochemistry. Primary MC/MG cultures obtained from the spinal cord of IFN-γ-treated EAE mice that were ex vivo re-stimulated with a low dose (1 ng/ml) of IFN-γ and neuroantigen, promoted a significantly higher induction of CD4+ regulatory T (Treg) cells associated with increased transforming growth factor (TGF)-β secretion. Additionally, IFN-γ-treated primary MC/MG cultures produced significantly lower nitrite in response to LPS challenge than control MC/MG. IFN-γ-treated EAE mice had a significantly higher frequency of CX3CR1high MC/MG and expressed lower levels of program death ligand 1 (PD-L1) than PBS-treated mice. Most CX3CR1highPD-L1lowCD11b+Ly6G- cells expressed MG markers (Tmem119, Sall2, and P2ry12), indicating that they represented an enriched MG subset (CX3CR1highPD-L1low MG). Amelioration of clinical symptoms and induction of CX3CR1highPD-L1low MG by IFN-γ were dependent on STAT-1. RNA-seq analyses revealed that in vivo treatment with IFN-γ promoted the induction of homeostatic CX3CR1highPD-L1low MG, upregulating the expression of genes associated with tolerogenic and anti-inflammatory roles and down-regulating pro-inflammatory genes. These analyses highlight the master role that IFN-γ plays in regulating microglial activity and provide new insights into the cellular and molecular mechanisms involved in the therapeutic activity of IFN-γ in EAE.